These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 29651853
1. OLEOGEL-S10 TO ACCELERATE HEALING OF DONOR SITES: MONOCENTRIC RESULTS OF PHASE III CLINICAL TRIAL. Lipový B, Fiamoli M, Mager R, Jelínková Z, Jarkovský J, Chaloupková Z, Holoubek J, Suchánek I, Brychta P. Acta Chir Plast; 2018; 59(3-4):129-134. PubMed ID: 29651853 [Abstract] [Full Text] [Related]
2. Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up. Frew Q, Rennekampff HO, Dziewulski P, Moiemen N, BBW-11 Study Group, Zahn T, Hartmann B. Burns; 2019 Jun; 45(4):876-890. PubMed ID: 30559054 [Abstract] [Full Text] [Related]
8. Accelerating the aesthetic benefit of wound healing by triterpene. Metelmann HR, Brandner J, Schumann H, Bross F, Hoffmann M, Podmelle F. J Craniomaxillofac Surg; 2012 Jul; 40(5):e150-4. PubMed ID: 21872485 [Abstract] [Full Text] [Related]
9. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years. Torres Pradilla M, Álvarez E, Novoa M, Lozano I, Trujillo M. Adv Ther; 2024 Feb; 41(2):867-877. PubMed ID: 38170434 [Abstract] [Full Text] [Related]
10. Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study. Schwieger-Briel A, Kiritsi D, Schempp C, Has C, Schumann H. Dermatol Res Pract; 2017 Feb; 2017():5068969. PubMed ID: 28611842 [Abstract] [Full Text] [Related]
11. Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program. Barret JP, Podmelle F, Lipový B, Rennekampff HO, Schumann H, Schwieger-Briel A, Zahn TR, Metelmann HR, BSH-12 and BSG-12 study groups. Burns; 2017 Sep; 43(6):1284-1294. PubMed ID: 28400148 [Abstract] [Full Text] [Related]
13. Birch Bark Extract: A Review in Epidermolysis Bullosa. Heo YA. Drugs; 2023 Sep; 83(14):1309-1314. PubMed ID: 37658982 [Abstract] [Full Text] [Related]
14. Influence of the Oil Phase and Topical Formulation on the Wound Healing Ability of a Birch Bark Dry Extract. Steinbrenner I, Houdek P, Pollok S, Brandner JM, Daniels R. PLoS One; 2016 Sep; 11(5):e0155582. PubMed ID: 27219110 [Abstract] [Full Text] [Related]
15. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex). Laszczyk M, Jäger S, Simon-Haarhaus B, Scheffler A, Schempp CM. Planta Med; 2006 Dec; 72(15):1389-95. PubMed ID: 17091432 [Abstract] [Full Text] [Related]
19. A randomized, double-blind, phase I clinical trial of fetal cell-based skin substitutes on healing of donor sites in burn patients. Momeni M, Fallah N, Bajouri A, Bagheri T, Orouji Z, Pahlevanpour P, Shafieyan S, Sodeifi N, Alizadeh A, Aghdami N, Fatemi MJ. Burns; 2019 Jun; 45(4):914-922. PubMed ID: 30559055 [Abstract] [Full Text] [Related]
20. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. Huyke C, Reuter J, Rödig M, Kersten A, Laszczyk M, Scheffler A, Nashan D, Schempp C. J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378 [Abstract] [Full Text] [Related] Page: [Next] [New Search]